Statin and PAF in Patients With Pacemaker
NCT00201552 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-09-20
Summary
Statin could decrease AF burden
Conditions
- Paroxysmal Atrial Fibrillation
Interventions
- DRUG
-
Statin
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Jiunn-Lee Lin, MD, PhD · National Taiwan University Hospital
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Taiwan
Study Locations
More Related Trials
-
Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial
NCT00256152 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter
NCT00115791 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
NCT03656523 ·Status: COMPLETED
-
Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation.
NCT00035451 ·Status: COMPLETED ·Phase: PHASE3
-
Atrial Pacing for Termination and Prevention of Atrial Fibrillation
NCT00123344 ·Status: COMPLETED ·Phase: NA
-
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
NCT02145546 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimal Ablation Strategies for Persistent AF With HF
NCT07153718 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
NCT00000556 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation
NCT00035477 ·Status: COMPLETED ·Phase: PHASE3
-
Atrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-up
NCT03607123 ·Status: UNKNOWN
-
Atrial Fibrillation Occurring Transiently With Stress (AFOTS)
NCT03221777 ·Status: COMPLETED
-
Impact of an Atrial Fibrillation Decision Support Tool (AFDST) on Thromboprophylaxis for Atrial Fibrillation
NCT02524977 ·Status: COMPLETED ·Phase: NA
-
Atrial Fibrillation Incidence, Risk Factors and Genetics
NCT00021905 ·Status: COMPLETED
-
Atrial Fibrillation Trial To Eliminate Risk-factors
NCT05718336 ·Status: COMPLETED
-
Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation
NCT00161538 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.
NCT07077811 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation
NCT00938730 ·Status: COMPLETED ·Phase: PHASE2
-
Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)
NCT01661205 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of CryoCor™ Cryoablation for PAF
NCT00231296 ·Status: COMPLETED ·Phase: NA
-
PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)
NCT00839566 ·Status: TERMINATED ·Phase: PHASE4
-
APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation
NCT00111527 ·Status: COMPLETED ·Phase: PHASE3
-
ST-segment Elevation as an AF Endophenotype
NCT01205529 ·Status: COMPLETED ·Phase: NA
-
Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden
NCT03311139 ·Status: COMPLETED
-
Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial
NCT01597557 ·Status: COMPLETED ·Phase: NA
-
LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.
NCT06021808 ·Status: RECRUITING ·Phase: NA